SCHEMBL13656309

SCHEMBL13656309

COOSNc1ccc(CCC(=O)NC/C=C/c2ccc(C)c(Cl)c2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 2/20 0.57
GRIN2B Q13224 2/20 0.57
KCNH2 Q12809 1/20 0.57
HPGD P15428 3/20 0.39
KMT2A Q03164 5/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM1A O60341 3/20 0.38
MAPT P10636 3/20 0.37
MEN1 O00255 2/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
POLB P06746 2/20 0.36
RECQL P46063 1/20 0.35
RAB9A P51151 2/20 0.35
S1PR1 P21453 1/20 0.35
ATM Q13315 1/20 0.35
NPC1 O15118 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13656209 0.93 GRIN1 (0.67) GRIN1GRIN2BKCNH2KMT2AKDM1A
SCHEMBL12576449 0.84 GRIN1 (0.65) GRIN1GRIN2BKCNH2HPGDKMT2A
SCHEMBL13656130 0.78 GRIN1 (0.69) GRIN1GRIN2BKCNH2KMT2AALDH1A1
SCHEMBL12575967 0.76 GRIN1 (0.77) GRIN1GRIN2BKCNH2
SCHEMBL13656223 0.73 PYGL (0.60) GRIN1GRIN2BKCNH2KMT2APOLB
SCHEMBL13656204 0.73 GRIN1 (0.64) GRIN1GRIN2BKCNH2KMT2AMAPT
SCHEMBL2022158 0.73 GRIN1 (1.00) GRIN1GRIN2BKCNH2
SCHEMBL2022155 0.73 GRIN1 (1.00) GRIN1GRIN2BKCNH2
SCHEMBL13656210 0.71 KMT2A (0.56) GRIN1GRIN2BKCNH2KMT2AALDH1A1
SCHEMBL13656205 0.70 GRIN1 (0.52) GRIN1GRIN2BKCNH2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420680-B2 NMDA receptor antagonists for neuroprotection EMORY UNIVERSITY (US) 2013-04-16 US disclosed
US-20090253710-A1 NMDA Receptor Antagonists for Neuroprotection EMORY UNIVERSITY 2009-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253710-A1 NMDA Receptor Antagonists for Neuroprotection GRIN1, GRIN2C, GRIK1 GRIN1 1/4885GRIN2B 7/4885KCNH2 137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.